Godavari Biorefineries Limited

As of June 30, 2026, Godavari Biorefineries Limited carries a market capitalization of 14.73B, placing it among publicly traded companies globally. Its enterprise value stands at 14.73B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Godavari Biorefineries Limited has 51.17M shares outstanding.

As of June 30, 2026, Godavari Biorefineries Limited trades at a trailing price-to-earnings ratio of 6,554.57.

As of June 30, 2026, Godavari Biorefineries Limited trades at an EV/EBITDA multiple of 16.24 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.73 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 41.78 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 14.73B versus a market cap of 14.73B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 11.64M in revenue per employee across its workforce of 1,729.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Godavari Biorefineries Limited recorded 7.98M in income tax expense. That works out to an effective tax rate of 77.99, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 10.23M, leaving 2.25M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Godavari Biorefineries Limited's stock has declined approximately 17.73% over the past 52 weeks. The 50-day moving average sits at 237.78, while the 200-day moving average is 274.24.

Over the twelve months ended June 30, 2026, Godavari Biorefineries Limited generated 20.13B in revenue and converted that into 2.25M in net income, yielding earnings per share of 0.04. EBITDA reached 907.40M, while operating income came in at 663.99M.

Over the twelve months ended June 30, 2026, Godavari Biorefineries Limited posted a gross margin of 27.75, reflecting its pricing power and cost economics. The operating margin of 3.30 and net profit margin of 0.01 provide insight into operational efficiency.